Who
Anthony E. Maida III
Director and Cmo - Trans. Med.
Company insider
Files Form 4 as: Director and Cmo - Trans. Med., Mateon Therapeutics; Director, Innovate Biopharmaceuticals; Director, Spectrum Pharmaceuticals; Director, Vitality Biopharma; Director, Oncosec Medical.
In numbers
- Trades disclosed
- 149
- Buys
- 2
- Sells
- 20
- Bought
- $24K
- Sold
- $1.5M
- Companies
- 5
- Companies where not an officer
- 4
- First trade
- 20 Feb 2007
- Last trade
- 10 Jul 2026
- Last filed
- 14 Jul 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 10 Jul 2026filed 14 Jul 2026 | Mateon Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,500 at $0.00 | filing |
| 10 Jul 2026filed 14 Jul 2026 | Oncotelic Therapeuticsoption or derivative | SEC FORM 4 Code A | —1,500 at $0.00 | filing |
| 3 Sep 2021filed 8 Sep 2021 | Oncotelic Therapeuticsoption or derivative | SEC FORM 4 Code A | —600,000 at $0.00 | filing |
| 8 Jul 2021filed 16 Jul 2021 | Oncotelic Therapeuticsoption or derivative | SEC FORM 4 Code A | —400,000 at $0.00 | filing |
| 31 Mar 2021filed 16 Jul 2021 | Oncotelic Therapeutics | SEC FORM 4 Code C | —938,646 | filing |
| 31 Mar 2021filed 16 Jul 2021 | Oncotelic Therapeuticsoption or derivative | SEC FORM 4 Code C | —938 | filing |
| 24 Apr 2020filed 4 May 2020 | Innovate Biopharmaceuticalsoption or derivative | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 31 May 2019filed 4 Jun 2019 | Innovate Biopharmaceuticalsoption or derivative | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 29 May 2019filed 31 May 2019 | Spectrum Pharmaceuticalsoption or derivative | SEC FORM 4 Code M | —50,000 at $0.00 | filing |
| 29 May 2019filed 31 May 2019 | Spectrum Pharmaceuticals | SEC FORM 4 Code M | $305K50,000 at $6.09 | filing |
| 29 May 2019filed 31 May 2019 | Spectrum Pharmaceuticals | SEC FORM 4 Sold | $330K42,643 at $7.75 | filing |
| 8 May 2019filed 13 May 2019 | Vitality Biopharmaoption or derivative | SEC FORM 4 Code A | —500,000 at $0.00 | filing |
| 11 Apr 2019filed 12 Apr 2019 | Spectrum Pharmaceuticals | SEC FORM 4 Sold | $115K10,738 at $10.67 | filing |
| 21 Mar 2019filed 22 Mar 2019 | Spectrum Pharmaceuticalsoption or derivative | SEC FORM 4 Code M | —5,500 at $0.00 | filing |
| 21 Mar 2019filed 22 Mar 2019 | Spectrum Pharmaceuticals | SEC FORM 4 Code M | $28K5,500 at $5.05 | filing |
| 21 Mar 2019filed 22 Mar 2019 | Spectrum Pharmaceuticals | SEC FORM 4 Sold | $55K5,500 at $10.00 | filing |
| 21 Feb 2019filed 22 Feb 2019 | Spectrum Pharmaceuticalsoption or derivative | SEC FORM 4 Code M | —5,500 at $0.00 | filing |
| 21 Feb 2019filed 22 Feb 2019 | Spectrum Pharmaceuticals | SEC FORM 4 Code M | $28K5,500 at $5.05 | filing |
| 21 Feb 2019filed 22 Feb 2019 | Spectrum Pharmaceuticals | SEC FORM 4 Sold | $64K5,500 at $11.63 | filing |
| 24 Jan 2019filed 25 Jan 2019 | Spectrum Pharmaceuticalsoption or derivative | SEC FORM 4 Code M | —1,550 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.